Bethany Jean Jansen, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10242 Madison Oaks Rd, Festus, MO 63028 Phone: 314-803-3101 |
Freedom Of Speech Therapy Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1371 Ymca Dr, Festus, MO 63028 Phone: 636-465-0726 Fax: 636-465-0747 |
Charles Stapinski, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 376 Festus Center Drive, Festus, MO 63028 Phone: 636-931-2100 Fax: 636-931-2300 |
Katherine R Meyer, OCCUPATIONAL THERAPI Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: #5 Industrial Drive, Festus, MO 63028 Phone: 636-933-1162 Fax: 636-933-1579 |
Haley Fay Finnegan, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1120 W Commerce Dr Ste 100, Festus, MO 63028 Phone: 636-224-7511 |
Paul Kohler, MSOT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1300 Veterans Blvd, Suite C, Festus, MO 63028 Phone: 636-931-2100 Fax: 636-931-2300 |
Shelly Blankenship, MS,OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1330 Ymca Dr, Suite 1200, Festus, MO 63028 Phone: 314-313-1088 |
Kaitlyn Lee Wilkinson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1371 Ymca Dr, Festus, MO 63028 Phone: 636-465-0726 |
Ms. Laura Ann Bequette, O.D., OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 223 Main St, Festus, MO 63028 Phone: 636-937-2399 Fax: 366-937-4683 |
News Archive
Since early in the pandemic, COVID-19 has been associated with heart problems, including reduced ability to pump blood and abnormal heart rhythms.
Millions of U.S. drivers cross faulty or obsolete bridges every day, highway statistics show, but it's too costly to fix all these spans or adequately monitor their safety, says a University of Maryland researcher who's developed a new, affordable early warning system.
In the American government's biodefense efforts, the potential for terrorists to cause a deadly anthrax outbreak remains a significant concern, six years after the letter attacks that shook the nation shortly after 9/11.
The Leukemia & Lymphoma Society applauds the FDA's recent approval of two new drugs - daratumumab and ixazomib - to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S. Advances in treatments for many different types of blood cancers are happening with dizzying speed and these two approvals in just one week are the latest evidence of this phenomenon.
The development of prediction models that included variables such as pretreatment sexual function, patient characteristics and treatment factors appear to be effective at predicting erectile function 2 years after prostatectomy, external radiotherapy, or brachytherapy for prostate cancer, according to a study in the September 21 issue of JAMA.
› Verified 3 days ago